Tempus AI Operating Income 2025-2024 | TEM

Tempus AI annual/quarterly operating income history and growth rate from 2025 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Tempus AI operating income for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
  • Tempus AI operating income for the twelve months ending June 30, 2024 was $0M, a NAN% increase year-over-year.
  • Tempus AI annual operating income for 2023 was $0B, a NAN% decline from 2022.
  • Tempus AI annual operating income for 2022 was $0B, a NAN% decline from .
  • Tempus AI annual operating income for was $0B, a NAN% decline from .
Tempus AI Annual Operating Income
(Millions of US $)
2023 $
2022 $
Tempus AI Quarterly Operating Income
(Millions of US $)
2024-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $8.309B $0.000B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $42.008B 22.60
Inspire Medical Systems (INSP) United States $6.038B 1124.89
Hims & Hers Health (HIMS) United States $3.817B 222.13
Axonics (AXNX) United States $3.550B 0.00
10x Genomics (TXG) United States $2.732B 0.00
Enovis (ENOV) United States $2.437B 17.66
Azenta (AZTA) United States $2.415B 137.17
IRhythm Technologies (IRTC) United States $2.276B 0.00
Privia Health (PRVA) United States $2.162B 150.67
Omnicell (OMCL) United States $1.979B 65.18
Clover Health Investments (CLOV) United States $1.403B 0.00
Schrodinger (SDGR) United States $1.364B 0.00
Phreesia (PHR) United States $1.313B 0.00
Standard BioTools (LAB) United States $0.713B 0.00
Fulgent Genetics (FLGT) United States $0.641B 0.00
Definitive Healthcare (DH) United States $0.520B 441.00
Health Catalyst (HCAT) United States $0.503B 0.00
Talkspace (TALK) United States $0.341B 0.00
Butterfly Network (BFLY) United States $0.336B 0.00
Pulmonx (LUNG) United States $0.325B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.244B 0.00
TruBridge (TBRG) United States $0.179B 13.12
American Well (AMWL) United States $0.142B 0.00
P3 Health Partners (PIII) United States $0.140B 0.00
Augmedix (AUGX) United States $0.116B 0.00
EUDA Health Holdings (EUDA) Singapore $0.099B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Zepp Health (ZEPP) China $0.060B 0.00
SHL Telemedicine (SHLT) Israel $0.052B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.037B 0.00
Outset Medical (OM) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.022B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.022B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Syra Health (SYRA) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00